Preventing and Treating AMR Resistant Topical Infections Utilizing Novel Sustained Release Phage Spray and Patch Systems
Lead Product–Prevention of AMR Infections.
Lead Product - Lysigen
Treating multiple bacterial conditions utilizing first or best-in-class lysins. Lead products are for the treatment of eczema and acne. See further Phagelux subsidiary Lysigen at www.lysigen.com.
According to WHO, if we don't take action, we will enter the post-antibiotic era, in which a common infection and minor injury can be life-threatening. It is estimated that by 2050 more people will die from infection than from cancer.